• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.

作者信息

Eisen Alon, Bhatt Deepak L

机构信息

Brigham and Women's Hospital Heart &Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

出版信息

Nat Rev Cardiol. 2015 Aug;12(8):445-6. doi: 10.1038/nrcardio.2015.87. Epub 2015 Jun 9.

DOI:10.1038/nrcardio.2015.87
PMID:26054831
Abstract
摘要

相似文献

1
Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.抗血小板治疗：确定药物洗脱支架置入术后双重抗血小板治疗的最佳持续时间。
Nat Rev Cardiol. 2015 Aug;12(8):445-6. doi: 10.1038/nrcardio.2015.87. Epub 2015 Jun 9.
2
Dual antiplatelet therapy duration after percutaneous coronary intervention with drug-eluting stents: how short can we go?药物洗脱支架经皮冠状动脉介入治疗后双联抗血小板治疗的持续时间：我们能缩短到多短？
Minerva Cardioangiol. 2020 Oct;68(5):436-450. doi: 10.23736/S0026-4725.20.05196-8. Epub 2020 Sep 29.
3
Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).外周动脉疾病患者冠状动脉植入药物洗脱支架后的血小板反应性及临床结局：来自ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）的分析
Circ Cardiovasc Interv. 2017 Mar;10(3). doi: 10.1161/CIRCINTERVENTIONS.116.004904.
4
Bleeding versus thrombosis: role of short DAPT in complex lesions.出血与血栓形成：短期双联抗血小板治疗在复杂病变中的作用
Minerva Cardioangiol. 2015 Dec;63(6):533-46. Epub 2015 Sep 2.
5
Current developments in dual antiplatelet therapy after stenting.支架置入术后双联抗血小板治疗的当前进展
Minerva Cardioangiol. 2014 Jun;62(3):261-76.
6
Omitting aspirin in PCI patients: Myth or reality?经皮冠状动脉介入治疗（PCI）患者中阿司匹林的应用：是误区还是现实？
Cardiovasc Drugs Ther. 2019 Dec;33(6):711-724. doi: 10.1007/s10557-019-06916-7.
7
Optimal duration of dual antiplatelet therapy after PCI: integrating procedural complexity, bleeding risk and the acuteness of clinical presentation.PCI术后双联抗血小板治疗的最佳疗程：整合手术复杂性、出血风险及临床表现的紧急程度
Expert Rev Cardiovasc Ther. 2018 Oct;16(10):735-748. doi: 10.1080/14779072.2018.1523718. Epub 2018 Oct 4.
8
Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?
Med Princ Pract. 2015;24(4):398. doi: 10.1159/000381955. Epub 2015 Apr 22.
9
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.COMBO双药治疗支架治疗急性冠状动脉综合征患者短期双联抗血小板治疗的随机评估：REDUCE试验的原理与设计
Am Heart J. 2016 Aug;178:37-44. doi: 10.1016/j.ahj.2016.04.016. Epub 2016 Apr 29.
10
Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.药物洗脱支架置入术后短期（≤6个月）与长期（≥12个月）双重抗血小板治疗：一项随机临床试验的荟萃分析
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):34-40. doi: 10.1002/ccd.25520. Epub 2014 May 6.

引用本文的文献

1
Preoperative Assessment and Management of Cardiovascular Risk in Patients Undergoing Non-Cardiac Surgery: Implementing a Systematic Stepwise Approach during the COVID-19 Pandemic Era.非心脏手术患者心血管风险的术前评估与管理：在新冠疫情时代实施系统的逐步方法
J Cardiovasc Dev Dis. 2021 Oct 3;8(10):126. doi: 10.3390/jcdd8100126.
2
Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.经皮冠状动脉介入治疗和药物洗脱支架置入术后双联抗血小板治疗：系统评价和网络荟萃分析。
Circulation. 2020 Oct 13;142(15):1425-1436. doi: 10.1161/CIRCULATIONAHA.120.046308. Epub 2020 Aug 3.
3

本文引用的文献

1
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.药物洗脱支架经皮冠状动脉介入治疗后双重抗血小板治疗的最佳持续时间：随机对照试验的荟萃分析
BMJ. 2015 Apr 16;350:h1618. doi: 10.1136/bmj.h1618.
2
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.药物洗脱支架置入后短期与长期双联抗血小板治疗：一项个体患者数据的两两比较和网络荟萃分析。
J Am Coll Cardiol. 2015 Mar 24;65(11):1092-102. doi: 10.1016/j.jacc.2014.12.046.
3
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.
Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.
冠状动脉疾病双联抗血小板治疗的持续时间：一篇综述文章。
Curr Atheroscler Rep. 2016 Jul;18(7):45. doi: 10.1007/s11883-016-0595-0.
急性心肌梗死患者和非急性心肌梗死患者PCI术后延长疗程双重抗血小板治疗的获益与风险
J Am Coll Cardiol. 2015 May 26;65(20):2211-21. doi: 10.1016/j.jacc.2015.03.003. Epub 2015 Mar 15.
4
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.药物洗脱支架置入术后接受延长双联抗血小板治疗患者的死亡率：随机试验的成对和贝叶斯网状荟萃分析。
Lancet. 2015 Jun 13;385(9985):2371-82. doi: 10.1016/S0140-6736(15)60263-X. Epub 2015 Mar 14.
5
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.药物洗脱支架置入术后12个月或30个月的双联抗血小板治疗。
N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.
6
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组编写，欧洲经皮心血管介入协会（EAPCI）提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
7
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.药物洗脱支架和金属裸支架的短期和长期结果：来自随机试验的 117762 患者年随访的混合治疗比较分析。
Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.
8
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南。美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告。
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.
9
Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.药物洗脱支架的合理使用：在降低再狭窄与关注晚期血栓形成之间取得平衡。
Lancet. 2008 Jun 21;371(9630):2134-43. doi: 10.1016/S0140-6736(08)60922-8.
10
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.氯吡格雷与阿司匹林联用对比单用阿司匹林预防动脉粥样硬化血栓形成事件
N Engl J Med. 2006 Apr 20;354(16):1706-17. doi: 10.1056/NEJMoa060989. Epub 2006 Mar 12.